This resistance is associated with upregulation of HIF-1α, a transcription factor that enhances glycolytic metabolism and is further regulated by the PI3K/AKT pathway—one of the key dysregulated signaling pathways in cancer [197,198]. This evidence concerns the gene AKT1 and cancer.